The Netherlands, with its internationally recognized medical education infrastructure and its state of the art patient care system, is highly successful in pioneering ground breaking medical research.
Optimal geographic characteristics and a high hospital “density” add to its ideal base for clinical research activities. CR2O is a recently established research organization co-founded by Prof Ab Osterhaus, that focusses on managing and operating clinical trials for vaccine-, drug-, and diagnostics development by industry and public organizations.
CR2O closely collaborates with leading clinics and research centers in Europe. Erasmus Medical Center (Erasmus MC), including Rotterdam University Hospital, is an important liaison to CR2O. Being well-known worldwide for academic expertise in viral and other infectious diseases, with state of the art clinical infrastructure and high quality research facilities (e.g. BSL 2-3 research and diagnostic labs), Erasmus MC harbours several WHO reference centers for infectious diseases.
Together with Viroclinics Biosciences BV -an Erasmus MC spin-out that provides high quality laboratory services to major pharmaceutical companies- CR2O participates in a worldwide network of virology laboratories. Collectively this dynamic clinical and research infrastructure provides CR2O with a unique position as a new service provider (i.e. research and expertise center) entering the field of clinical trials for infectious disease interventions, to test new generations of vaccines, drugs, and diagnostic approaches.